Imipramine Crescent Pharma (Imipramine Hydrochloride)

Imipramine blocks the reuptake of norepinephrine and serotonin, two key neurotransmitters. By preventing their removal from the synaptic cleft, it raises their levels, which helps improve mood, reduce anxiety, and influence urinary control mechanisms.

The appropriate dose is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Dosage adjustments are made during treatment to achieve optimal therapeutic effect while minimizing side effects.

Safety data for imipramine in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and consider alternative treatments when appropriate. Women who are pregnant or nursing should discuss options with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imipramine belongs to the tricyclic antidepressant class, which differs from newer agents such as SSRIs and SNRIs. TCAs generally have a broader side‑effect profile but can be effective when patients do not respond to newer drugs. Choice of therapy depends on individual response, tolerability, and clinical judgment.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually with a glass of water. It may be prescribed to be taken once daily or in divided doses, depending on the clinician’s assessment. Patients should follow the prescribing information and not alter the dosing schedule without medical advice.

Serious risks include cardiac arrhythmias, seizures, severe hypotension, and rare cases of agranulocytosis or hepatic dysfunction. Patients should be monitored for cardiovascular symptoms, changes in mental status, and any signs of severe allergic reactions.

Individuals with known hypersensitivity to imipramine or other tricyclic antidepressants, those currently taking MAO inhibitors, patients with recent myocardial infarction, and persons with uncontrolled narrow‑angle glaucoma should avoid using this medication.